Cargando…

Epithelial mucin core antigen (EMCA) in assessing therapeutic response in advanced breast cancer--a comparison with CA15.3.

We report a comparative study of CA 15.3 and EMCA (epithelial mucin core antigen) in 77 consecutive women with newly diagnosed UICC assessable metastatic breast cancer, 59 patients received hormones and 18 chemotherapy. Assessments of response were made prior to commencing therapy and repeated 2 mon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dixon, A. R., Price, M. R., Hand, C. W., Sibley, P. E., Selby, C., Blamey, R. W.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1993
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968729/ https://www.ncbi.nlm.nih.gov/pubmed/8217608

Ejemplares similares

Primary Cutaneous Mucinous Carcinoma Monitoring: A Role for CA15.3 and CEA?
por: Ginguay, Antonin, et al.
Publicado: (2022)

The tumour associated antigen CA15.3 in primary breast cancer. Evaluation of 667 cases.
por: Gion, M., et al.
Publicado: (1991)

Serum CA549 in primary breast cancer: comparison with CA15.3 and MCA.
por: Gion, M., et al.
Publicado: (1994)

Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases
por: Nicolini, Andrea, et al.
Publicado: (2006)

Detection of secondary metastatic breast cancer by measurement of plasma CA 15.3
por: De Cock, L., et al.
Publicado: (2021)

Symptomatic metastasis prediction with serial measurements of CA 15.3 in primary breast cancer patients
por: Bahrami-Ahmadi, Amir, et al.
Publicado: (2012)

Polymorphisms of MUC16 (CA125) and MUC1 (CA15.3) in Relation to Ovarian Cancer Risk and Survival
por: Williams, Kristina A., et al.
Publicado: (2014)

CA15.3 Serum Concentrations in Older Women with Infiltrating Ductal Carcinomas of the Breast
por: Ruibal, Álvaro, et al.
Publicado: (2014)

Utility of C-erbB-2 in tissue and in serum in the early diagnosis of recurrence in breast cancer patients: comparison with carcinoembryonic antigen and CA 15.3.
por: Molina, R., et al.
Publicado: (1996)

C595--a monoclonal antibody against the protein core of human urinary epithelial mucin commonly expressed in breast carcinomas.
por: Price, M. R., et al.
Publicado: (1990)

Intestinal Antigenicity of Ovarian Mucinous Cystadenomas
por: Nairn, R. C., et al.
Publicado: (1971)

Objective measurement of therapeutic response in breast cancer using tumour markers.
por: Robertson, J. F., et al.
Publicado: (1991)

Serum cancer antigen 15.3 concentrations in patients with betathalassemia minor compared to those with cancer and healthy individuals
por: Shahriari, Mahdi, et al.
Publicado: (2014)

The Organon, Section 153
por: Fitz, W. H. A.
Publicado: (1888)

sFlt-1 and CA 15.3 are indicators of endothelial damage and pulmonary fibrosis in SARS-CoV-2 infection
por: Greco, Marilena, et al.
Publicado: (2021)

Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance
por: Hing, J.X., et al.
Publicado: (2020)

Different Levels of CEA, CA153 and CA125 in Milk and Benign and Malignant Nipple Discharge
por: Zhao, Song, et al.
Publicado: (2016)

Muon capture in $^{151}$Eu and $^{153}$Eu
por: Petitjean, C, et al.
Publicado: (1972)

Polymorphic epithelial mucin from the sera of advanced breast cancer patients--isolation and partial characterisation.
por: O'Sullivan, C., et al.
Publicado: (1990)

Circulating CA 15-3 antigen levels in non-mammary malignancies.
por: Colomer, R., et al.
Publicado: (1989)

Monoclonal antibodies reacting with the MUC2 mucin core protein.
por: Devine, P. L., et al.
Publicado: (1993)

Fungal Planet description sheets: 128–153
por: Crous, P.W., et al.
Publicado: (2012)

The prognostic role of variations in tumour markers (CEA, CA15.3) in patients with metastatic breast cancer treated with CDK4/6 inhibitors
por: Sottotetti, Federico, et al.
Publicado: (2022)

The decay of /sup 153/Ho to the transitional N=87 nucleus /sup 153/Dy
por: Paris, P, et al.
Publicado: (1981)

Nuclear moments and mean square charge radii of $^{140-153}$Eu
por: Ahmad, S A, et al.
Publicado: (1984)

Properties of superdeformed bands in $^{153}$Dy
por: Cederwall, Bo, et al.
Publicado: (1994)

Recognition of the Polypeptide Core of Mucin by Monoclonal Antibody MUSE11 against an Adenocarcinoma‐associated Antigen
por: Hinoda, Yuji, et al.
Publicado: (1990)

Ocular Metastasis in Elderly Lung Cancer Patients: Potential Risk Factors of CA-125, CA-153 and TPSA
por: Ge, Qian-Min, et al.
Publicado: (2020)

CA-125, CA-153, and CYFRA21-1 as clinical indicators in male lung cancer with ocular metastasis
por: Li, Biao, et al.
Publicado: (2020)

Value of TCT combined with serum CA153 and CA50 in early diagnosis of cervical cancer and precancerous lesions
por: Li, Heyue, et al.
Publicado: (2022)

The capsid lattice engages a bipartite NUP153 motif to mediate nuclear entry of HIV-1 cores
por: Shen, Qi, et al.
Publicado: (2023)

Monoclonal Antibody Recognizing a Core Epitope on Mucin
por: Devine, Peter L., et al.
Publicado: (1998)

Tumour-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA 125) in mucinous ovarian tumours.
por: Mogensen, O., et al.
Publicado: (1990)

A comparison of the clinical metastatic patterns of invasive lobular and ductal carcinomas of the breast.
por: Dixon, A. R., et al.
Publicado: (1991)

The Organon, Section 153
por: Wells, P. P.
Publicado: (1881)

Utilidad del marcador tumoral Ca 15.3 en el diagnóstico del cáncer de mama en el Hospital Regional ISSSTE Veracruz : /
por: Rodríguez Aguilar, Ricardo
Publicado: (2014)

An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies
por: Perrier, Alexandre, et al.
Publicado: (2020)

Mucin gel assembly is controlled by a collective action of non-mucin proteins, disulfide bridges, Ca(2+)-mediated links, and hydrogen bonding
por: Meldrum, Oliver W., et al.
Publicado: (2018)

An evaluation of mucin-like carcinoma associated antigen (MCA) in breast cancer.
por: Cooper, E. H., et al.
Publicado: (1989)

Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk
por: Broderick, Peter, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_p580eiaukdf1u7e3sguabfgucs